This case series examines the efficacy of anifrolumab as a therapeutic option for patients with lupus erythematosus.
No takes yet. Share an insight, caveat, or question.
Shaw et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: